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Abstract
Rationale Dopamine D2-like receptors (D2R) are important drug targets in schizophrenia and Parkinson’s disease, but D2R ligands
also cause cognitive inflexibility such as poor reversal learning. The specific role of D2R in reversal learning remains unclear.
Objectives We tested the hypotheses that D2R agonism impairs reversal learning by blocking negative feedback and that
antagonism of D1-like receptors (D1R) impairs learning from positive feedback.
Methods Male Lister Hooded rats were trained on a novel visual reversal learning task. Performance on Bprobe trials^, during
which the correct or incorrect stimulus was presented with a third, probabilistically rewarded (50% of trials) and therefore
intermediate stimulus, revealed individual learning curves for the processes of positive and negative feedback. The effects of
D2R and D1R agonists and antagonists were evaluated. A separate cohort was tested on a spatial probabilistic reversal learning
(PRL) task after D2R agonism. Computational reinforcement learningmodelling was applied to choice data from the PRL task to
evaluate the contribution of latent factors.
Results D2R agonism with quinpirole dose-dependently impaired both visual reversal and PRL. Analysis of the probe trials on
the visual task revealed a complete blockade of learning from negative feedback at the 0.25 mg/kg dose, while learning from
positive feedback was intact. Estimated parameters from the model that best described the PRL choice data revealed a steep and
selective decrease in learning rate from losses. D1R antagonism had a transient effect on the positive probe trials.
Conclusions D2R stimulation impairs reversal learning by blocking the impact of negative feedback.
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Introduction
Cognitive flexibility is required to navigate in a changing en-
vironment and requires both new associative learning and the
ability to disregard rules when they become obsolete.
Impairments in neuropsychological tests designed to measure
such flexibility, e.g. reversal learning, are observed in psychi-
atric and neurological disorders including schizophrenia
(Leeson et al. 2009) and Parkinson’s disease (PD; (Cools
et al. 2007)). Despite this, current drug treatments often fail
to remediate cognitive impairment in schizophrenia (e.g.
(Leeson et al. 2009)); in the case of PD, the same drugs that
restore voluntary movement by increasing dopamine (DA)
tone in the dorsal striatummay even contribute to impairments
in reversal learning, perhaps by Boverdosing^ the relatively
intact ventral striatum with DA or DA D2-like receptor
(D2R) agonists (Swainson et al. 2000).
Electrophysiological experiments in animals have shown
that, in healthy individuals, the activity of DA neurons corre-
lates reliably with a theoretical reward prediction error: firing
rates increase in response to unexpected reward and decrease
after unexpected reward omission (Schultz 2013). The causal
link between this neuronal activity and reinforcement learning
has been demonstrated using optogenetic approaches in rats,
from the perspectives of both positive (Steinberg et al. 2013)
and negative prediction errors (Chang et al. 2016). In agree-
ment with these studies, DA activity also provides a prediction
error signal during reversal learning, transiently declining in
response to errors after a shift in response-outcome contingen-
cies and increasing after unexpected rewards, as the subjects
begin to interact with the previously non-rewarded, now
rewarded response option (Klanker et al. 2015; Verharen
et al. 2018).
At the level of the striatum, which receives the majority of
midbrain DA output, D2R and D1-like receptors (D1R) are
segregated between striatopallidal (indirect-pathway) and
striatonigral (direct-pathway) neurons, respectively (Gerfen
et al. 1990). Since D1R stimulate and D2R inhibit cAMP
production, striatonigral neurons are predicted to increase
cAMP and downstream signalling in response to positive pre-
diction errors when dopamine levels transiently increase,
whereas striatopallidal neurons instead respond more to neg-
ative prediction errors when dopamine levels decrease (Yapo
et al. 2017). In seminal work by Frank and colleagues, rein-
forcement learning was altered in PD patients only after they
had taken their dopaminergic medication (Frank et al. 2004):
there was a selective reduction in learning from losses in a
probabilistic selection task (PST), in which subjects solved
two-choice visual discrimination problems either by learning
to approach the positive stimuli or by learning to avoid the
negative stimuli (Frank et al. 2004). A proposed explanation
was that supraphysiological levels of DA block learning from
negat ive feedback by rendering D2R-expressing
striatopallidal neurons indifferent to dips in dopamine (which
would impair learning from negative feedback) .
Hypodopaminergic states, in contrast, would not allow D1R-
expressing striatonigral cells to detect DA burst firing (which
would impair learning from positive feedback) (Cox et al.
2015; Frank et al. 2004). Supporting this account, variation
in the DRD2 gene was linked to learning from losses in the
PST task, whereas a polymorphism in the DARPP32 gene,
intimately linked to D1R function (Calabresi et al. 2000), in-
stead predicted learning from wins (Frank et al. 2007).
Imaging experiments additionally revealed that D1R and
D2R radioligand binding correlates with learning from posi-
tive and negative feedback, respectively (Cox et al. 2015).
Further support for this view comes from the observation that
mice lever-press for optogenetic stimulation of striatonigral
neurons, whereas they avoid a lever linked to optogenetic
stimulation of striatopallidal neurons (Kravitz et al. 2012).
Whereas pharmacological evidence for this model of the basal
ganglia is still lacking, D2Rs have been heavily implicated in
reversal learning in humans (Clatworthy et al. 2009; Mehta
et al. 2001), non-human primates (Groman et al. 2011; Horst
et al. 2019; Lee et al. 2007), rats (Boulougouris et al. 2009)
and mice (Laughlin et al. 2011; Linden et al. 2018). The evi-
dence for D1R involvement in reversal learning, in contrast, is
equivocal; e.g., systemic treatment with a D1R agonist in mice
only transiently impaired visual reversal learning (Izquierdo
et al. 2006), and D1R antagonism in vervet monkeys did not
significantly affect reversal learning in an object reversal
learning task sensitive to D2R agents (Lee et al. 2007).
To investigate the specific roles for D1R and D2R in
reversal learning further, and based on recent advances in
cognitive tasks for rats and mice (Markou et al. 2013;
Nilsson et al. 2015; Phillips et al. 2018), we established
a novel touchscreen reversal-learning paradigm for rats, in
which standard two-choice visual discrimination trials
(CS+ vs. CS−) were interleaved with Bprobe^ trials, where
a stimulus of intermediate valence (C50/50) was presented
with either the CS+ or CS−. Assuming that the interme-
diate value of the C50/50 is known (by means of pre-train-
ing), subjects’ preference for the CS+ over the C50/50 re-
flects their learning from positive feedback on the standard
trials, whereas negative feedback should promote a prefer-
ence for the C50/50 over the CS−. We hypothesised that
D1R antagonism would cause subjects to pay less atten-
tion to positive outcomes and thus fail to prefer the CS+
over the C50/50 during reversal learning, whereas subjects
would become indifferent to negative feedback after D2R
agonism, and hence not discriminate between the CS− and
C50/50. A number of reference manipulations were tested,
including the effect of D2R activation on computationally
derived latent variables guiding behaviour in a separate
group of rats tested in a serial spatial probabilistic reversal
task (Bari et al. 2010).
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Materials and methods
Compliance with ethical standards
This research has been regulated under the Animals (Scientific
Procedures) Act 1986 Amendment Regulations 2012 (Project
licence 70/7548) following ethical review by the University of
Cambridge Animal Welfare and Ethical Review Body
(AWERB).
Subjects
Male Lister Hooded rats (Charles River, Kent, UK) were
allowed to acclimatise to the animal facility under a
12 h:12 h light cycle (lights off at 7 AM) for a minimum of
7 days before any procedures began. Rats were housed in
groups of 4 on wood-chip bedding in standard cages with
cardboard tunnels as enrichment. When rats reached a body
weight of approximately 300 g, they were food-restricted to
maintain approximately 90% of their free-feeding weight tra-
jectory (17.5–19 g of Purina rodent chow per animal and day;
adjusted for reward pellet consumption during testing). Water
was available ad libitum in the home cage. The experiments
used a total of 124 rats (for details, see Table 1).
Drugs
All drugs were dissolved in saline and injected via the intra-
peritoneal route. Raclopride (Tocris Bioscience, Bristol, UK)
was administered at 0, 0.015, 0.03, and 0.06 mg/kg, 20 min
before testing. SCH39166 hydrobromide (Tocris Bioscience)
was administered at 0, 0.025, 0.05, and 0.1 mg/kg, 20 min
before testing. Note that SCH39166 was chosen for D1R an-
tagonism to avoid off-target effects at the serotonin 5-HT2C
receptor, since activity at this receptor affects visual reversal
learning (Alsiö et al. 2015). SKF81297 hydrobromide (Tocris
Bioscience) was administered at 0, 0.1, and 0.25 mg/kg,
30 min before testing. (−)-Quinpirole hydrochloride (Sigma-
Aldrich, St. Louis, MO, USA) was administered at 0, 0.01,
0.025, 0.1, 0.25, and 0.5 mg/kg, 60 min before testing. A
broad dose range of quinpirole was chosen to allow detection
of potential differential effects of canonical presynaptic and
postsynaptic doses (Eilam and Szechtman 1989). No adverse
reactions to repeated injections were observed in any
experiments.
Visual discrimination and reversal
Behavioural apparatus
Food-restricted rats were tested in 16 operant chambers (Med
Associates, Georgia, VT, USA; 30 cm × 39 cm × 29 cm)
placed in sound-attenuating MDF boxes with fans for the
purpose of ventilation and masking external noise. A food
receptacle centrally placed in one wall of the chamber was
connected to an external pellet dispenser delivering 45 mg
sucrose pellet (TestDiet 5TUL). A house light was located
near the ceiling directly above the magazine. The wall oppo-
site to the food receptacle was replaced by a touchscreen (Elo
Touch Solutions, Inc). The chambers were controlled by in-
house software (Visual Basic 2010 Express.NET, Microsoft
2010; developed by A.C.M.).
Pre-training
Initial touchscreen training is described in detail elsewhere
(Alsiö et al. 2015); see Supplementary Table 1 for an over-
view. Rats were tested once daily, 5–6 days a week, through-
out the experiments. Briefly, the rats were first trained to touch
a large white rectangular stimulus on the screen for a sugar
reward, until receiving 100 rewards within 60min. A 5-s inter-
trial interval was employed throughout all procedures. Next,
the animals were required to press a medium-sized rectangle
and finally a small (3 × 4 cm) Bstart box^, located at the bot-
tom centre of the touchscreen. The criterion for moving on
from each stage was reaching 100 responses/rewards within
60 min. During the next phase of training, pressing the start
box, instead of providing pellets, lead to the presentation of a
single visual stimulus on the touchscreen (BHorizontal^ or
BVertical^; counterbalanced across rats and alternating be-
tween days), randomly presented left or right on the screen.
Touching the stimulus lead to reward delivery whereas press-
ing the no-stimulus (black) side lead to a 5-s timeout, during
which the house light was turned on. In order to prevent acci-
dental contact with the screen, while at the same time promot-
ing quick progress in the training, the stimulus was presented
further down on the screen for the first sessions but moved up
to approximately 7 cm height once the rat had reached > 80%
correct (out of 100 trials) across 2 days. When the rat had
reached > 80% on two consecutive sessions with the higher
stimulus position, pre-training was complete.
Touchscreen visual discrimination and reversal
During the next stage of training, trials were initiated by press-
ing the start box as above, but rats were required to discrimi-
nate between two stimuli presented simultaneously on the
screen (CS+ vs. CS−; BHorizontal^ or BVertical^;
counterbalanced across rats). The animals were tested until
the session they reached the running learning criterion of 24
correct in 30 trials at least once during a session (reaching
criterion did not terminate the session). This visual discrimi-
nation phase normally required 1–3 days of training. A reten-
tion session was included the day after rats initially reached
criterion. In addition, another retention session was then in-
cluded before the stimulus-outcome contingencies were
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reversed. Rats were then trained on the reversed conditions
until they reached the same criterion (24/30); this normally
required 4–8 days of training. A single retention session was
again included after rats reached criterion on reversal. See
Electronic Supplementary Material for a description of the
serial reversal learning task (cohort IV; cf. Table 1).
Valence-probe visual discrimination task with reversal
After the pre-training reversal was completed, the rats
progressed to the valence-probe visual discrimination (VPVD)
task. Here, the trial structure was kept constant but a tone was
played every time a trial was rewarded and the stimulus duration
was unlimited, meaning no omissions could occur. In addition, a
third stimulus, probabilistically rewarded on average 50% of the
time and therefore termed C50/50, was paired with either the CS+
or CS− on Bprobe^ trials (Fig. 1). Initially (Experiment 1), 16
rats were trained on theVPVD reversal task (seemethod, below)
to compare the impact of different probe stimuli (BDiamonds^
and BRings^) and frequency of probe-trial presentations (every 4
or 5 trials). For each condition, n = 4. Rats trained with the
BDiamonds^ stimulus and an average probe-trial frequency of
Table 1 Experimental cohorts and stimuli used in the visual tasks
Cohort Discrimination & TSVR 
A B 
VPVD pre-training
A B   
C 50/50
VPVD1
A B
C 50/50
VPVD2
A B
C 50/50
PRL
Left    
Right
-
I (n=16) No drug Task 
development
Task 
development
n/a n/a
II (n=32) No drug No drug SKF81297 Quinpirole n/a
III (n=16) No drug No drug SKF81297 Quinpirole n/a
IV (n=32) SCH39166 /
Raclopride
No drug SCH39166 /
Raclopride
n/a n/a
V (n=16) No drug No drug SCH39166 / 
Raclopride
n/a n/a
VI (n=12) n/a n/a n/a n/a Quinpirole
Stimulus-outcome contingencies were counterbalanced across drug groups. A different probe stimulus (C50/50) exemplar was tested in some rats in the
task development experiment (not shown). TSVR, touchscreen serial visual reversal task; VPVD, valence-probe visual discrimination task; PRL,
probabilistic reversal learning task (spatial)
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every 4 trials (see Fig. 1a, b) displayed better performance on
both visual discrimination and on reversal than other combina-
tions (data not shown).
After optimisation, the probe stimulus was set to BDiamonds^
and each of the probe trials (CS+ vs. C50/50 or C50/50 vs. CS−)
was presented once every 8 trials; randomised but never on the
first trial within any 8-trial bin. The rats received a maximum of
200 trials per session (i.e. 150 standard trials CS+ vs. CS−; 25
trials CS+ vs. C50/50; 25 trials of C50/50 vs. CS−). As during pre-
training, both the inter-trial interval and the timeout (on non-
rewarded trials) was 5 s. No omissions were allowed in the
VPVD task, in order to ensure that the rats completed the probe
trials. See Supplementary Fig. 1 for a comparison of the trial
structure in the different behavioural tasks.
Rats were initially tested for 5 days on the same CS+ and
CS− as during the pre-training reversal above (i.e.
BHorizontal^ vs. BVertical^). The animals then completed a
visual discrimination with a novel pair of stimuli (BSlash^ vs.
BBackslash^; counterbalanced across rats; CS+ and CS− is
here referred to as A+ and B− during visual discrimination).
Training continued for a minimum of 5 sessions, but was
extended for any rat to allow them to reach 80% correct on
the standard (A+ > B−) trials within the task. Next, the rats
received a vehicle (saline) injection and were given a retention
test session (on rare occasions, rats were given a second re-
tention session with saline injection to achieve the 80% inclu-
sion criterion). On the next day, rats were matched for
stimulus-reward contingencies, performance on the probe tri-
als before reversal and pre-training reversal performance, and
randomly allocated to a drug group according to the experi-
ment (Table 1). The stimulus-reward contingencies were re-
versed before the session and testing on the reversal phase
continued for 10–14 days. The drug corresponding to each
rat was administered before testing each day. Note that during
reversal, the CS+ and CS− are referred to as B+ and A−,
respectively. Note also that the same stimulus exemplar (i.e.
BDiamonds^) was used as the probe stimulus for all rats and
across each of the phases: pre-training on the VPVD task,
initial visual discrimination and during the reversal phase.
As shown in Table 1, the same cohorts (II and III) received
both SKF81297 and subsequently quinpirole; training during the
quinpirole experiment followed the same procedure as above but
rats were trained up on a new pair of stimuli (BArcs^ vs.
BTriangles^; counterbalanced across rats; note that the probe-
stimulus exemplar, i.e. BDiamonds^, was kept the same also
throughout the second visual discrimination and reversal phase)
before reversal of the new stimulus-reward contingencies (CS+
and CS− is referred to as B+ and A− during reversal). In this
case, the allocation into drug groups was also balanced based on
previous drug exposure. It should also be noted that the
SCH39166 and raclopride cohort had been trained on a high
number of serial reversals before being tested on the VPVD task
(Table 1; see Electronic Supplementary Material).
Statistical analysis of data from the VPVD task
On the VPVD reversal task, main measures were percentage
correct responses (%Correct) on the standard A− < B+ trials
Standard trials
Posive probe
Negave probe
Approach/avoid
Approach posive
Avoid negave
Discriminaon Reversal Trials
150
25
25
Learning process
A- < B+
B+ > C50/50
A- < C50/50
A+ > B-
A+ > C50/50
B- < C50/50
> > >
C50/50 < B+
A- < C50/50
a b
c
Fig. 1 Trial structure and learning curves for the three trial types in the
valence-probe visual discrimination (VPVD) reversal task. a Example
trial sequence. b Regular two-choice trials during both visual discrimina-
tion (A+ > B−) and subsequent reversal learning (A− < B+) are inter-
leaved with Bprobe^ trials. During such trials, a third stimulus that is
probabilistically linked to reward (50/50% chance of reward/no reward;
C50/50) is presented with either the positive or the negative stimulus. c)
Rats are below chance on the first day of reversal on all three trial types,
indicating the influence of previously learned associations in the form of
both stimulus perseveration (preference for previously rewarded stimulus,
A−, over C50/50) and learned non-reward (avoiding previously non-
rewarded stimulus, B+, when presented with C50/50). Choice behaviour
on probe trials over the course of the reversal indicates how much the
animals have learned from positive and negative feedback, respectively.
Learning curves show mean ± standard error of the mean (SEM)
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and performance on the probe trials across sessions (number
of trials where the highest reward-probability option was cho-
sen, i.e. B+ on B+ > C50/50 trials and C50/50 on A− < C50/
50 trials; %Optimal choice). These scores were arcsine-
transformed for statistical analyses, but are presented as non-
transformed values in the figures. %Correct was analysedwith
a mixed-model ANOVAwith Dose (3–6 levels) and Sessions
(10 or 14 levels) as between- and within-subject factors, re-
spectively. %Optimal choice was analysed in a mixed-model
ANOVAwith Dose (3–6 levels) as a between-subjects factor
and Trial Type (2 levels) and Sessions (10 or 14 levels) as
within-subject factors. Behaviour on the probe trials was then
analysed further with two-way ANOVA for positive (B+ vs.
C50/50) and negative probes (C- vs. C50/50), separately.
Data from the standard (A− <B+) trials were also divided
into separate phases depending on the performance of rats during
running blocks of 30 trials (Alsiö et al. 2015). Only data up to
(and including) the first block of 30 trials where a rat reached
criterion (24 correct) were analysed. Trials were divided into
BEarly ,^ in which the rats had less than 11 corrects in a running
block of 30 trials, and BLate^ if the rats scored higher than 19
correct in any block of 30 trials; all other trials were treated as
BMid^. The number of errors in each phase was calculated and
square-root transformed. Repeated-measures ANOVAwere then
performed with two within-subject factors: phase (3 levels) and
dose (4 levels). We also analysed performance on the first rever-
sal session (Alsiö et al. 2015; Izquierdo et al. 2006). Auxiliary
measures were latencies to respond to the different stimuli and
latencies to collect reward (log-transformed from latencies in
milliseconds and averaged across sessions; Table 2 shows the
corresponding average latencies in milliseconds). For repeated-
measures variables, the Greenhouse-Geisser correction was
employed when prompted by significant Mauchly’s tests of
sphericity. Testing of two rats was aborted and their data exclud-
ed due to computer malfunction (quinpirole 0.25 mg/kg, n = 1;
raclopride 0.03 mg/kg, n = 1).
Serial spatial probabilistic reversal task
Apparatus
Testing took place in Campden Instruments (BBussey-Saksida^)
touchscreen chambers controlled by ABETII (Lafayette
Instruments) and Whisker control software (Cardinal and
Aitken 2010). The chambers were housed inside fibreboard box-
es with fans for ventilation and to exclude noise. They were
equippedwith touchscreenmonitors, tone generators, LEDhouse
lights and a magazine unit with light and infrared beam to detect
head entries (opposite side to the touchscreen); a pellet dispenser
delivered 45-mg sucrose pellets (TestDiet 5TUL). The chambers
had a trapezoidal shape to guide the rats’ attention to the screen
and food receptacle.We used a 5-hole Bmask^ to seal off most of
the touchscreen; positions 2 and 4 were used throughout testing.
Pre-training
We adapted the established serial PRL task (Bari et al.
2010) for touchscreen chambers controlled by ABETII soft-
ware written by B.U.P. See Supplementary Table 1 for an
overview. Briefly, 12 rats underwent one Habituation ses-
sion where ca. 30 pellets were freely available in the food
Table 2 Latencies to respond at the screen and to collect sucrose pellets
on rewarded trials
Experiment Response latency (ms) Collection latency (ms)
Expt. 2 (VPVD)
Quinpirole
Vehicle 1066 ± 38 1529 ± 50
0.01 mg/kg 1231 ± 76 1786 ± 114
0.025 mg/kg 1261 ± 119 1916 ± 133*
0.1 mg/kg 1179 ± 59 2257 ± 104***
0.25 mg/kg 1183 ± 126 2559 ± 118***
0.5 mg/kg 1213 ± 93 2556 ± 102***
Expt. 3 (VPVD)
SKF81297
Vehicle 1122 ± 65 1379 ± 45
0.1 mg/kg 1279 ± 98 1436 ± 50
0.25 mg/kg 1064 ± 74 1612 ± 70**
Expt. 4 (TSVR)
SCH39166
Vehicle 1061 ± 71 970 ± 61
0.025 mg/kg 1137 ± 69 1126 ± 68
0.05 mg/kg 1167 ± 72 1227 ± 106
0.1 mg/kg 1190 ± 69* 1438 ± 122*
Raclopride
Vehicle 1247 ± 91 968 ± 73
0.015 mg/kg 1171 ± 78 1013 ± 68
0.03 mg/kg 1300 ± 119 1168 ± 98*
0.06 mg/kg 1386 ± 118* 1392 ± 134*
Expt. 4 (VPVD)
Vehicle 1047 ± 39 1344 ± 45
SCH39166 (0.05) 1209 ± 72 1508 ± 76
Raclopride (0.03) 1094 ± 66 1424 ± 41
Expt. 5 (PRL)
Quinpirole
Vehicle 1155 ± 179 1706 ± 72
0.025 mg/kg 2810 ± 467*** 2038 ± 94**
0.1 mg/kg 4608 ± 639** 3478 ± 905*
0.25 mg/kg 5321 ± 1171** 2879 ± 243**
VPVD, valence-probe visual discrimination; TSVR, touchscreen serial
visual reversal task; PRL, probabilistic reversal learning task. Group data
are mean ± standard error of the mean (SEM), collapsed across sessions
and reversal phases (Early, Mid, Late) in the TSVR and VPVD task.
*p < 0.05; **p < 0.01; ***p < 0.001 vs. vehicle-treated rats in each
experiment
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tray and no task was run. Next, in a single Conditioning
session, two white stimuli were presented on the screen;
after the rat touched either stimuli or after 30 s had passed,
the stimuli disappeared and a pellet was delivered to the
food tray. Rats earned a maximum of 100 pellets in this
session. If they did not complete all trials, the session ter-
minated after 60 min. Next, during Must Touch training, no
free pellets were delivered but rats could still press the
stimuli for reward. These sessions terminated following
60 min or after 100 rewards had been earned, whichever
occurred first. Next, animals were trained to initiate in the
food magazine to begin a trial. This training stage was
identical to Must Touch, except that all animals had to emit
an additional nosepoke in the magazine to commence each
trial. These sessions also terminated following either
60 min or after 100 pellets had been earned. Finally, all
animals were trained on a Punish Incorrect stage. This was
identical to the previous initiation stage except that re-
sponses at a non-target location were punished with a brief
(5 s) timeout.
Experimental procedure
All animals were then trained on the full serial PRL procedure.
This was conducted as per the final training stage, except that
at the beginning of the session, one side stimulus was random-
ly assigned a reward probability of 80% and the other a reward
probability of 20%. Following eight consecutive Bcorrect^
responses (responses to the 80% reward-probability side),
the contingencies reversed so that the previously 20%-
rewarded stimulus became 80%-rewarded and vice versa.
These sessions terminated following either 60 min or after
200 trials had been completed. Once performance stabilised
at a high level, drug administration experiments commenced.
This was conducted as a within-subject Latin square, with all
animals receiving all doses of quinpirole and vehicle control
in a counterbalanced, pseudorandom order. For these experi-
ments, administration sessions were always separated by a
baseline session with no drug administration.
Statistical analyses and modelling of data
from the probabilistic serial spatial reversal task
The main measures from the PRL task were the number of
reversals completed per session, the win-stay probability, i.e.
P(choose the same stimulus | rewarded on the last trial), and
the lose-shift probability, i.e.P(choose the alternative stimulus
| unrewarded on the last trial). We also analysed auxiliary
measures including latency to respond and to collect rewards.
Conventional statistical analyses (ANOVA) were applied to
these measures.
Computational reinforcement learning modelling of choice
data
In order to better describe the choice data from the PRL task,
we applied a set of hierarchical Bayesian reinforcement learn-
ing models designed to reveal latent variables that were in-
volved in behavioural choice. Four models were evaluated
(see also Electronic Supplementary Material). The first
contained parameters for reward rate (αwin), which described
the learning rate on rewarded trials; punishment rate (αloss),
which described the learning rate on non-rewarded trials; and
a softmax inverse temperature parameter (β), which described
the degree to which choices either strongly followed stimulus
value (high β) or were more stochastic (low β). The second
model contained all of the above parameters and an additional
side stickiness parameter (τ), which was designed to capture
the tendency for animals to simply repeat choices at the same
spatial location. The third model had a combined learning rate
for rewards and punishments, a side stickiness parameter, and
an inverse temperature parameter. The final model was a ver-
sion of the Experience-Weighted Attraction model, which in-
cludes a parameter for the influence of previous associations
(cf. (den Ouden et al. 2013)).
All models were fitted to the behavioural data by Monte
Carlo sampling in Stan 2.17.2 (Stan Development Team;
http://mc-stan.org) and subsequently compared by bridge
sampling, which generates estimates of the marginal
likelihood (Gronau et al. 2017a). This was implemented via
the R package Bbridgesampling^ (Gronau et al. 2017b) and
reveals the Bayesian posterior probability of eachmodel given
both the prior model probability and empirical data. The mean
values for each parameter per group from the winning model
are presented alongside the Bayesian 95% highest posterior
density interval (HDI). Drug effects vs. vehicle were also
sampled and evaluated as 95% HDI, which provides a robust
posterior difference estimate for each parameter.
The parameters from the winning model were further eval-
uated by a set of simulations. Specifically, we simulated groups
of rats (n = 40 per dose) with parameter values randomly drawn
from the distribution of the estimated parameters from each
drug group in the actual experiment (0; 0.025; 0.1; and
0.25 mg/kg). Each simulated rat then completed the PRL task
in a virtual environment, updating the Q values and probabili-
ties of choosing left and right (see Electronic Supplementary
Material for details) depending on the four individual parame-
ters corresponding to that rat (αwin, αloss, τ and β) and the trial-
by-trial feedback from the task, including probabilistically
rewarded response options (80%/20%) and reversals after 8
Bcorrect^ choices in a row.
In addition, to test whether quinpirole-induced changes in
individual parameters were sufficient to affect choice behav-
iour, we created sets of simulated rats (n = 40 per condition)
where all but one parameter were drawn from the estimated
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parameter distribution for vehicle-treated rats; the last param-
eter was drawn from the parameter distribution of quinpirole
rats. Finally, we tested the necessity of parameters of interest
to drive the change in behaviour, by drawing e.g. αloss from its
distribution for vehicle rats and drawing the remaining three
parameters (αwin, τ, and β) from the relevant parameter distri-
bution of quinpirole-treated rats.
Results
Experiment 1: Optimisation of the VPVD task
The VPVD task was optimised with regard to probe stimulus
exemplar and probe trial frequency (Fig. 1a, b), so that rats
displayed below-chance performance in probe trials for learn-
ing from both negative feedback (A− < C50/50) and positive
feedback (B+ > C50/50) immediately following reversal (Fig.
1c). This indicated that the task, at these parameters, allowed
us to tap into both learned non-reward (avoiding the previous-
ly negative, now positive stimulus; B+) and stimulus persev-
eration (approaching the previously positive, now negative
stimulus; A−). All further testing was performed using these
parameters.
Experiment 2: Effects of D2R agonism with quinpirole
on reversal learning
Initial inspection of the reversal data after quinpirole treatment
revealed that behaviour was disrupted by the highest dose
(0.5 mg/kg), with rats in this group completing fewer trials
than controls (one-way ANOVA: F5,41 = 4.59; p = 0.002; sig-
nificant reduction in trials only at 0.5 mg/kg dose; data not
shown). Quinpirole treatment also dose-dependently in-
creased latency to collect rewards (F5,41 = 13.9; p < 0.001;
Table 2) but had no impact on latency to respond (F5,41 < 1;
NS). Due to the effects on trials completed, we excluded the
0.5 mg/kg dose from further analyses.
Quinpirole treatment impaired performance in the VPVD
reversal learning task. On the standard (A− < B+) trials, there
was a main effect of Dose (F4,34 = 6.83, p < 0.001) and a Dose
× Session interaction (F18.4,156 = 2.38, p = 0.002). Post hoc
analysis (Sidak’s method) revealed that the 0.25 mg/kg dose
reduced %Correct from session 7 onwards (See Fig. 2a). The
number of errors on the standard (A− < B+) trials were also
analysed after trials were split into early (< 11 correct in 30
trials), mid, and late (> 19 correct in 30 trials) phases (Alsiö
et al. 2015): there was a significant effect of Dose (F4,34 =
2.82; p = 0.04) but no Dose × Phase interaction (F8,68 < 1;
NS). See Fig. 2b. Post hoc analysis (Fisher’s LSD) suggested
that the 0.25 mg/kg increased overall errors compared to ve-
hicle (p = 0.025).
Quinpirole differentially affects learning from positive
and negative feedback
The quinpirole-induced impairment of reversal learning was
accompanied by a selective effect on the negative probe trials
(Fig. 2c, d). When analysing the %Optimal choice on the two
types of probe trials in a (three-way) ANOVA, we observed a
significant Dose × Session × Valence (positive vs. negative)
interaction (F22.6,191 = 1.86; p = 0.014), indicating that the ef-
fect of Dose differed between positive and negative probe
trials across sessions.
Choice performance on the positive and negative probe trials
was next analysed separately. On the positive-valence probe
trials (B+ >C50/50), there was no effect of Dose (F4,34 = 2.01;
p = 0.11) or Dose × Session interaction (F21.9,186 = 1.22, NS).
On negative-valence probe trials (A− < C50/50), in contrast,
there was a main effect of Dose (F4,34 = 8.86, p < 0.001) and a
significant Dose × Session interaction (F30.6,260 = 2.37,
p < 0.001). Sidak’s post hoc comparisons revealed that the
0.25 mg/kg dose impaired performance consistently from ses-
sion 7 onwards. Impairments were also observed for the
0.1 mg/kg dose from session 9 onwards.
When%Correct on the standard (A− < B+) trials of the first
day was analysed separately, there was no significant main
effect of Dose (F4,43 = 1.65; NS). When performance on the
probe trials on the first day was examined using a two-way
ANOVA with Dose as a 5-level between-subjects factor and
Valence as a 2-level within-subjects factor, there were also no
effect of Dose (F4,34 = 2.11; p = 0.10) or Dose × Valence in-
teraction (F4,34 < 1; NS), but a significant effect of Valence
(F1,34 = 11.4; p = 0.002).
It should be noted that the exclusion or inclusion of the
0.5 mg/kg quinpirole group did not affect the overall pattern
of results. Importantly, the three-way interaction with Dose ×
Session ×Valence remained significant alsowhen the 0.5mg/kg
dose was included (F31.1,255 = 1.82; p = 0.007). In addition, pre-
vious drug history (SKF81297, Experiment 3, see below) did
not significantly affect any choice measure in the quinpirole
experiment (main effect and all interactions, p > 0.1) and the
three-way interaction Dose (of quinpirole) × Session ×
Valence remained significant in analyses of variance where
SKF81297 drug history was included as a between-subjects
factor, regardless of whether all quinpirole doses were analysed
together (F30.7,178 = 1.94; p = 0.004) or whether the highest
quinpirole dose was excluded (F21.8,131 = 2.08; p = 0.006).
Experiment 3: No effect of the D1R agonist SKF81297
on choice behaviour in the VPVD task
The D1R agonist SKF81297 had no appreciable effects on
reversal learning overall (Fig. 3a). In a two-way ANOVA,
there was no main effect of Dose (F2,45 < 1; NS) on perfor-
mance on the standard (A− < B+) trials, and no Dose ×
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Fig. 3 Lack of impact of the D1-
receptor agonist SKF81297 on
reversal learning in the VPVD
task. SKF81297 did not affect
learning overall at either
0.1 mg/kg (n = 16) or 0.25 mg/kg
(n = 16) vs. vehicle (n = 16). a
%Correct on standard A− < B+
trials across the 14 days of treat-
ment. b Numbers of errors on
standard A− < B+ trials (probe
trials excluded) during early, mid,
and late phases of the reversal. c
No significant effect of
SKF81297 on performance on
positive probe trials. d) No effect
of SKF81297 on choice behav-
iour on negative probe trials.
Graphs show mean ± SEM for
each dose and session
Fig. 2 The dopamine D2-like re-
ceptor agonist quinpirole im-
paired visual reversal learning in
the novel VPVD reversal task
(n = 7–8 for each group). a
Quinpirole at 0.25 mg/kg reduced
correct responses on standard A−
< B+ trials. b Quinpirole at
0.25 mg/kg increased the number
of errors on standard A− < B+
trials across the learning phases
(early: < 11 correct in any 30 tri-
als; late: > 19 correct in any 30
trials, but before the criterion of
24 correct). c There was no effect
on performance on the B+ >C50/50
trials, indicating intact learning
from positive feedback. d
Quinpirole dose-dependently im-
paired performance on the A− <
C50/50 trials, indicating impaired
learning from losses. Note that rats
treated with quinpirole 0.25 mg/kg
fail to improve over chance per-
formance on negative probe trials
across the 14 days of testing.
Graphs show mean ± SEM for
each dose and session
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Session interaction (F8.39,189 < 1; NS). Performance on the
standard (A− < B+) trials were next split into early, mid, and
late phases, as above, and analysed in a two-way ANOVA.
There was no significant effect of Dose (F2,45 < 1; NS) or a
Dose × Phase interaction (F3.11,69.9 = 1.95; p = 0.13) on errors
in the different phases (Fig. 3b).
The combined effects of Dose and Session on %Optimal
choice were investigated in a three-way ANOVA (Fig. 3c, d).
There was no Dose × Session × Valence interaction (F11.1,251 =
1.25, NS), and also no significant main effect of Dose in the full
model (F2,45 < 1; NS). Despite the lack of a significant three-
way interaction, the performance on the positive and negative
probe trials was next analysed separately for potential trends in
the data. On positive probe trials, there was no significant effect
of Dose (F2,45 < 1; NS) and no significant Dose × Session in-
teraction (F12.6,283 = 1.14; NS). On negative probe trials, there
was similarly no effect of Dose (F2,45 < 1; NS) and no signifi-
cant Dose × Session interaction (F12.9,290 < 1; NS).
SKF81297 did not affect latencies to respond at the stimuli
(F2,45 = 1.80; NS) but did have an impact on reward collection
latencies (F2,45 = 4.41; p = 0.018); post hoc analyses revealed
that the 0.25 mg/kg dose increased the latency to collect the
reward (Table 2).
Experiment 4: Effects of D1R and D2R antagonism
on reversal learning
In a preliminary experiment, we evaluated a range of doses for
SCH39166 (0; 0.025; 0.05; 0.1 mg/kg) and raclopride (0;
0.015; 0.03; 0.06 mg/kg) on the touchscreen serial visual rever-
sal task (Electronic Supplementary Material). Doses used for
the VPVD task were based on a lack of effect on response
latencies; there were also no effects of SCH39166 or raclopride
on errors on the serial visual task (Supplementary Fig. 2).
In the VPVD reversal task, no significant overall effects were
detected after either D1R antagonism (SCH39166) or D2R an-
tagonism (raclopride) compared to vehicle-treated rats (Fig. 4a).
Percentage correct on standard (A− <B+) trials was investigated
with a two-way ANOVAwith Treatment (vehicle, SCH39166,
or raclopride) as a between-subjects factor and Session as a
within-subjects factor (10 levels). We observed no effect of
Treatment (F2,44 < 1; NS) and no Treatment × Session interac-
tion (F5.56,122 = 1.29; NS). We also analysed the performance on
the A− <B+ trials from the perspective of different phases in
reversal learning (early, mid and late; Fig. 4b). There was no
main effect of Treatment (F2,45 < 1; NS) and no Treatment ×
Phase interaction (F3.17,71.3 < 1; NS) in a two-way ANOVA.
Transient effect of D1R antagonism on positive feedback
Performance on the probe trials was investigated next (Fig.
4c, d). We observed no significant three-way Treatment ×
Session × Valence interaction (F10.1,221 < 1; NS) and no main
effect of Treatment (F2,44 < 1, NS) in the full model. To test the
a priori hypothesis that dopamine D1-receptor antagonism im-
pairs learning from positive feedback, we next investigated the
effects of SCH39166 and raclopride on positive and negative
probe trials separately (despite a lack of a significant three-way
interaction). On positive probe trials, there was no main effect
of Treatment (F2,44 < 1; NS) and no Treatment × Session
(F9.88,217 = 1.49; p = 0.15). On negative probe trials, there was
similarly no effect of Treatment (F2,44 < 1; NS) and no signifi-
cant Treatment × Session interaction (F11.2,247 < 1; NS).
We also tested the hypothesis that D1- and D2-receptor an-
tagonism preferentially affects early reversal learning. In a one-
way ANOVA with Treatment as the between-subject factor (3
levels), we found no significant effect on %Correct on the stan-
dard (A−<B+) trials on the first day of reversal (F2,45 < 1; NS).
In a two-way ANOVA with Treatment as a between-subjects
factor and Valence as a within-subjects factor, we observed a
significant main effect of Treatment (F2,45 = 5.45; p = 0.008)
but no effect of Valence (F1,45 < 1; NS) and no Treatment ×
Valence interaction (F2,45 < 1; NS). As we had a priori expecta-
tions about differential effects across learning from positive and
negative feedback, we investigated simple main effects despite
the lack of a significant two-way interaction. Analysis of simple
main effects using Fisher’s LSD comparisons revealed a signif-
icant effect of SCH39166 on the positive probe trials on the first
day (p = 0.033); all other comparisons were non-significant.
In agreement with our preliminary experiments, there was
no effect of SCH39166 or raclopride dose on latency to re-
spond in a one-way ANOVA (F2,45 = 1.83; NS); in a separate
ANOVA, there was also no significant effect on latency to
collect the reward (F2,45 = 1.73; NS). See Table 2.
Experiment 5: Effects on D2R agonism on a spatial
PRL task
Quinpirole impaired learning and increased latencies to respond
and collect rewards on the PRL (Fig. 5a–c; Table 2). In a one-
way ANOVA, quinpirole dose-dependently decreased the num-
ber of reversals completed (F3,33 = 13.4; p < 0.001); post hoc
analyses revealed that this effectwas significant at both 0.1mg/kg
and 0.25 mg/kg quinpirole (Fig. 5a). In a two-way ANOVAwith
Trial Type (win-stay, lose-shift) and Dose (4 levels) as within-
subject factors, there was a main effect of Dose (F3,33 = 13.8;
p < 0.001) but no Dose × Trial Type interaction (F3,33 < 1; NS).
We nevertheless investigated the trial types separately, as these
can be speculated to relate to learning from positive and negative
feedback, respectively (but see the computational analysis below,
for more robust measures). Quinpirole had a significant impact
on win-stay probability (F2.1,23.1 = 11.0; p < 0.001); post hoc
analyses revealed significantly decreased values for both
0.1 mg/kg and 0.25mg/kg (Fig. 5b). There was also a significant
effect of quinpirole on lose-shift performance (F3,33 = 6.41; p =
0.002); this effect was driven by the 0.25 mg/kg treatment
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(Fig. 5c). Furthermore, quinpirole increased latencies both to
respond on the screen (one-way ANOVA; F1.71,17.1 = 16.5; p
< 0.001) and to collect the sugar pellet (one-way ANOVA;
F1.51,15.1 = 9.25; p = 0.004) on rewarded trials. Post hoc anal-
yses showed that all doses of quinpirole increased both latency
to respond and collect rewards in the PRL (Table 2).
Hierarchical Bayesian modelling of PRL choice data
We next used hierarchical Bayesian analysis of reinforcement
learning to sample latent variables influencing behaviour in
the probabilistic spatial serial reversal task. Four different
models were compared; the best description of the choice data
(via bridge-sampled maximum likelihoods) was found to be
the model containing separate learning rates for wins (αwin)
and losses (αloss), a softmax inverse temperature parameter (β)
and a side stickiness parameter (τ). For details, see Electronic
Supplementary Material.
We explored the effect of drug treatment on the posterior
distributions of the group means for αwin, αloss, β, and τ (Fig.
5d). For αwin (learning rate for wins), 0.025 mg/kg increased
this measure relative to the vehicle condition (0 ∉ 95% HDI
for group differences). Conversely, 0.1 mg/kg decreased αwin
relative to vehicle treatment (0 ∉ 95% HDI for group differ-
ences). In contrast, the 0.25 mg/kg dose did not affect αwin.
There was a sharp decrease in αloss (learning rate for losses) at
the highest dose of quinpirole (0.25 mg/kg) compared to the
vehicle condition (0 ∉ 95% HDI for group differences). No
other doses exerted an effect on this parameter. Additionally,
high-dose (0.25 mg/kg) quinpirole increased β (inverse tem-
perature) relative to vehicle treatment (0 ∉ 95%HDI for group
differences), whereas other doses did not affect this parameter.
Finally, low-dose quinpirole (0.025 mg/kg) decreased τ (side
stickiness) relative to vehicle treatment (0 ∉ 95% HDI for
group differences), but no other differences in which the
95% HDI did not contain 0 were detected on this measure.
Fig. 4 Performance on the VPVD
reversal task after dopamine
receptor antagonism. D2-like re-
ceptor antagonism (raclopride;
0.03 mg/kg; n = 13) and D1-like
receptor antagonism (SCH39166;
0.05 mg/kg, n = 14) had no sig-
nificant effect versus vehicle
treatment (saline; n = 20). a
%Correct over each of 10 ses-
sions. b No effect on number of
errors on standard A− < B+ trials
committed during each of three
learning phases. c, d Performance
on probe trials. Raclopride and
SCH39166 did not significantly
affect learning overall on either
positive (B+ > C50/50) or negative
(A− < C50/50) trials. The graphs
show mean ± SEM for each dose
and session
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Simulated task performance: posterior predictive check
and role of individual model parameters in driving reversal
impairment
To interrogate the validity of the winning model and
better understand the contribution of changes in rein-
forcement learning parameters to overall performance,
we simulated the choice behaviour of agents on the
serial PRL task based on the extracted parameters in
the winning model. The simulations closely matched
the raw data on the main task measures, with dose-
dependent trends on reversals completed (Fig. 5e) and
win-stay and lose-shift proportions (Fig. 5f, g).
Next, we reasoned that the changes in task performance
detected following high-dose quinpirole administration could
be attributed to either the increase in β or the reduction inαloss.
To distinguish between these competing explanations, we car-
ried out simulations of task performance where virtual agents
would be allocated one extracted parameter from the
quinpirole group (0.25 mg/kg) and maintaining all other
parameters at vehicle levels (Clarke et al. 2014). This revealed
that simulating performance with only the high-dose αloss
values was sufficient to closely replicate the reversal
(Fig. 6a) and win-stay/lose-shift values (Fig. 6b, c) from the
high-dose quinpirole group; in contrast, agents with the high-
dose β values were, in fact, better than simulated vehicle rats
on both reversals completed and win-stay probability (Fig.
6a–c).
Having established that the change in high-dose αloss
was sufficient to replicate the impairments in task perfor-
mance, we also tested whether it was necessary to bring
about this pattern of results (Fig. 6d–f). To achieve this, we
carried out further simulations in which one parameter was
set to vehicle levels and the others were maintained at
high-dose quinpirole levels. This revealed that the reduc-
tion in αloss was necessary to recapitulate the impairments
that were observed in rats treated with high-dose
quinpirole. This effect was observed in number of reversals
completed (Fig. 6d) and in win-stay probability (Fig. 6e),
but less so in the lose-shift performance (Fig. 6f).
Fig. 5 The D2R agonist quinpirole impaired reversal learning in the PRL
task. a Dose-dependent decrease in the number of reversals completed
after quinpirole injections (mean ± SEM). b, c Quinpirole impaired both
win-stay (b) and lose-shift (c) performance (mean ± SEM). d 95% highest
posterior density intervals (HDI) for parameters estimated by hierarchical
Bayesian analysis of trial-by-trial choice data from the PRL task. The best
model was a reinforcement learning account with separate learning rates
for wins (αwin) and losses (αloss), inverse temperature (β), and side stick-
iness (τ). Quinpirole 0.25 mg/kg impaired learning rate after losses (αloss)
without affecting learning rate for wins (αwin). This dose also increased
the inverse temperature. e–g Using the winning model, we simulated rats
performing the reversal task in silico and updated their expected
outcomes (Q values; see Supplementary Online Material) on a trial-by-
trial basis using feedback such as probabilistically rewarded responses
and reversals after 8 correct responses in a row. For each simulated group
(n = 40/dose; graphs showmean ± SEM), parameter values were random-
ly drawn from the estimated distribution of the actual rats at the corre-
sponding dose. e Dose-dependent decrease in the number of reversals in
the simulation. f, g Win-stay and lose-shift analysis of choice data from
the simulated rats reveals that the behaviour of the actual rats is recovered
by the winning model. *p < 0.05 vs. vehicle; ***p < 0.001 vs vehicle;
#the 95% HDI for the difference score (vs. vehicle) excluded zero, i.e.
there is a > 95% probability that the drug effect was non-zero
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Discussion
We introduce a novel touchscreen paradigm that enables
investigation of how positive and negative feedback
shape behaviour in visual reversal learning. This is
achieved by intermittently inserted probe trials that in-
form how subjects track specific stimulus values across
changing stimulus-reward contingencies. In order to ex-
ploit the translational potential of the touchscreen
methodology, we tested two hypotheses pertaining to do-
paminergic influences on reversal learning, based in part
on the reinforcement learning data from the probabilistic
selection task in humans (Frank et al. 2004, 2007). We
found strong evidence for the hypothesis that D2R
agonism would impair reversal learning by selectively
blocking learning from losses. In contrast, we found only
weak evidence for an impact of D1R antagonism on
learning from positive feedback in the visual task. The
Fig. 6 Simulations reveal that the effects of quinpirole 0.25 mg/kg on the
αloss parameter is sufficient and necessary to drive reversal learning
impairment. a Test for sufficiency of the αloss parameter to drive
reversal impairment. In simulated vehicle-treated rats (BAll vehicle^;
see Fig. 5), impaired reversal learning is observed when the αloss param-
eter is replaced by values drawn from the estimated distribution of
quinpirole 0.25 mg/kg rats (BAll veh.:Quinp. αloss^). In contrast, replac-
ing the αloss parameter with β drawn from the distribution of quinpirole
0.25 mg/kg rats (BAll veh.: Quinp. β^) actually improves simulated per-
formance, as measured by reversals completed. b The same pattern is
observed on win-stay probabilities, where BAll veh.:Quinp. αloss^ rats
perform worse than both BAll vehicle^ and BAll veh.: Quinp. β rats^. c
On lose-shift probabilities, simulated vehicle-treated rats with either the
αloss or the β drawn from the distribution of quinpirole 0.25 mg/kg rats
display impaired performance on the virtual task. d Test for necessity of
the αloss parameter to drive reversal impairment. Simulated 0.25 mg/kg
quinpirole rats (BAll quinpirole 0.25^) perform the virtual task poorly (cf.
Figure 5). Replacing the αloss of these simulated rats with the values
drawn from the distribution of vehicle-treated rats (BAll quinp.:Veh.
αloss^) restores performance on the virtual task. In contrast, replacing only
the β with values drawn from vehicle rats (BAll quinp.:Veh. β^) does not
improve performance as measured by the number of reversals. e BAll
quinp.:Veh. αloss^ rats outperform both BAll quinpirole 0.25^ and BAll
quinp.:Veh. β^ on the win-stay probabilities. fOn lose-shift probabilities,
there were no differences between BAll quinpirole 0.25^ rats and the BAll
quinp.:Veh. αloss^ and BAll quinpirole 0.25^ groups. Graphs show mean
± SEM; n = 40 for each condition
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selective impairment in learning from negative feedback
after D2R agonism was substantiated using computation-
al analysis from another, spatial probabilistic reversal
task.
D2R stimulation selectively blunts learning
from losses in reversal learning
Quinpirole treatment severely impaired reversal learning at the
higher end of the dose range in both deterministic visual and
probabilistic spatial tasks. Whereas these observations are sup-
ported by previous studies where D2R agonism impaired rever-
sal learning in rats (Boulougouris et al. 2009), non-human pri-
mates (Smith et al. 1999) and healthy volunteers (Mehta et al.
2001), as well as by experiments linking variation in the DRD2
gene to reversal learning (Smith et al. 1999), our data extend
such findings by showing a dose-dependent and highly selective
effect of quinpirole on learning from negative feedback in the
novel VPVD reversal task for rats. Even after 14 days of training,
animals receiving high doses of quinpirole could not discrimi-
nate between the non-rewarded response option (A−) and the
probabilistically reinforced probe stimulus; at this stage, the rats
had learned to choose the B+ on the positive probe trials with
high accuracy. Under the assumption that quinpirole at the rele-
vant doses (≥ 0.1mg/kg) act on postsynaptic D2R in the striatum
to inhibit the activity of striatopallidal neurons, our data provide
support for the view that the indirect pathway of the basal ganglia
predominantly contributes to learning from negative feedback,
or avoidance learning (Cox et al. 2015; Frank et al. 2004).
Whereas this interpretation needs to be confirmed in future stud-
ies directly manipulating striatopallidal neurons or D2R within
the striatum, the present study adds receptor specificity to previ-
ous pharmacological data linking hyperdopaminergic states in
the rat to impaired learning from losses in reversal learning
(Verharen et al. 2018). In addition, the strong link between
D2R and learning from losses suggests a psychological mecha-
nism behind enhanced sensitivity to negative feedback and con-
comitant risk aversion after D2R pharmacology and interroga-
tion of D2R-positive neurons in the nucleus accumbens in the
study by Zalocusky et al. (Zalocusky et al. 2016).
Quinpirole also impaired performance in the PRL task,
where the number of reversals passed, as well as win-stay and
lose-shift behaviour, were all reduced in a dose-dependent man-
ner. Strikingly, parameter estimation using hierarchical
Bayesian analysis revealed a complete blockade of learning
from negative feedback (αloss) at the 0.25 mg/kg dose. In con-
trast, there was no effect on learning from positive feedback
(αwin) at this dose, although lower doses tended to either en-
hance (0.025 mg/kg) or reduce (0.1 mg/kg) this parameter. The
0.25 mg/kg dose also increased the inverse temperature param-
eter, β. Elevated β indicates higher reinforcement sensitivity
(less randomness or Bexploring^), suggesting that rats on
high-dose quinpirole were more guided by the expected
outcomes of responses; i.e., that rats would obey the trial-by-
trial Q values and Bexploit^ rather than Bexplore^. Hence, im-
pairments in reversal learning could logically be driven by ei-
ther decreased αloss or increased β (or their combination). (Note
that exploiting the expected value after a contingency reversal
leads to perseveration on the task, as long as theQ value for the
previously correct, now incorrect choice remains high.)
We used simulations to estimate the causal contribution to
reversal-learning deficits of the parameters that were affected
by 0.25 mg/kg quinpirole, i.e. αloss and β. We found that simu-
lated Bvehicle^ rats, whose values for the αloss parameter were
replaced with values drawn from the B0.25 mg/kg quinpirole^
group, were as poor on the virtual task as were the simulated
B0.25 mg/kg^ rats. In addition, we found that simulated
Bquinpirole 0.25^ mg/kg rats, whose values for the αloss param-
eter was replaced with values drawn from the Bvehicle^ group,
were significantly better than B0.25 mg/kg^ rats. No such effects
were observed for β. This suggests that the steep reduction in the
αloss parameter is both sufficient and necessary for the impair-
ments observed after 0.25 mg/kg quinpirole treatment. Taken
together, the quinpirole data from both tasks reveal an apparently
complete blockade in updating behaviour in response to losses in
reversal learning, manifested as an inability to learn to avoid the
CS− in the visual setting and an αloss approaching zero in the
PRL.
D2R stimulation does not affect learning
from positive feedback in the VPVD task
Quinpirole had no effect on performance on the positive probe
trials in the visual setting, and a less consistent effect on learn-
ing rate for wins in the spatial PRL task. Whereas a lack of
effect of D2R agonism on learning from positive feedback in
the visual task is in agreement with our hypothesis and the
reinforcement learning literature (Cox et al. 2015), the finding
is at odds with other results. For instance, studies by Groman
and colleagues showed that the D2R binding in the striatum of
vervet monkeys correlated with reactivity to positive feedback
in a reversal task (Groman et al. 2014, 2011). However, the
method used to measure learning from positive feedback in
those studies was win-stay behaviour. In the present PRL data,
we observed a strong reduction in win-stay probability in the
0.25 mg/kg group, but this did not, however, translate to al-
tered αwin. It is tempting to suggest that computational model-
ling provides a more nuanced account of behaviour than does
the win-stay analysis, by taking factors other than the imme-
diate response to reward into account when interpreting sub-
jects’ choices. In agreement with this, Verharen and col-
leagues recently found reduced win-stay probability in a spa-
tial deterministic reversal task after cocaine and amphetamine
pre-treatment, but a selective effect on αloss in the computa-
tional analysis (Verharen et al. 2018). Evidence in human
volunteers describes how D2R antagonism, which had no
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effect in our visual task, affected choice performance (inverse
temperature, β) but not reinforcement learning per se (learning
rate, α) in a task where learning was guided by rewards,
whereas no such effect was observed when learning was driv-
en by negative reinforcement (Eisenegger et al. 2014;
Pessiglione et al. 2006).
Low doses of quinpirole affect collection latencies not
choice performance
Lower doses of quinpirole (≤ 0.025 mg/kg), which may act
predominantly on presynaptic receptors (Ford 2014), failed to
alter choice performance in the visual paradigm. Nevertheless,
reward collection latencies were significantly slower at this
dose and upwards, indicating blunted motivation for the re-
ward. This shows that the 0.025 mg/kg dose was biologically
active and suggests that there is a dissociation between lower
and higher quinpirole doses on motivational and cognitive
aspects of the task. Speculatively, quinpirole reduces motiva-
tion at lower doses by acting on presynaptic autoreceptors to
inhibit activity in midbrain dopamine neurons. In line with
this view, quinpirole microinfusions into the ventral tegmental
area have been reported to reduce motivation for sucrose and
ethanol (Hodge et al. 1993), and RNA interference of D2
receptors (hence, reduced D2 autoreceptor activity) in the ven-
tral tegmental area increases motivation for sucrose and drug
reward (de Jong et al. 2015). Such presynaptic effects appear
insufficient to change reinforcement learning, both after D2R
silencing (de Jong et al. 2015) and in the present data set.
D1R and positive feedback
Dopamine D1R antagonism had no overall effect on reversal
learning, but caused a transient decrease in performance on the
positive probe trials, indicating impaired learning on the very
first reversal session. Thus, our hypothesis, that learning from
positive feedback would be selectively impaired by D1R an-
tagonism, gained no conclusive support. Nevertheless, our
observation of no overall impairment of D1R antagonism on
reversal learning is in agreement with a lack of effect of sys-
temic SCH23390 treatment on reversal learning in vervet
monkeys (Lee et al. 2007). Similarly, D1R agonism had no
effect on any of the main measures in this experiment; this is
in apparent contradiction with a previous reversal-learning
experiment where a transient effect on the first sessions was
observed after injections of the same drug in mice (Izquierdo
et al. 2006). It is conceivable that the performance-impairing
effects of D1R agonism and antagonism on neurons in the
striatum are confounded by enhancing effects at other sites
(e.g. in the cortex, although see (Calaminus and Hauber
2008)). In addition, our prediction of performance-impairing
effects of D1R antagonists was based on reports from discrim-
ination learning tasks (e.g. (Frank et al. 2007; Kravitz et al.
2012)), and we acknowledge that D1R may play additional or
opposing roles during reversal learning, where previous asso-
ciations have to be overcome for successful task performance.
Such opposing effects may be dose-dependent, and potentially
unmasked at alternative dose intervals than those used in the
current set of experiments. Taken together, future studies
should focus on the effects of D1R manipulations on, e.g.
initial visual discrimination learning or investigate the effects
of local micro-infusion of D1R agents into brain areas of in-
terest in rats performing reversal-learning tasks. Furthermore,
the failure of any dopamine agents tested here to affect learn-
ing to approach the positive stimulus warrants the investiga-
tion of drugs acting on other neuromodulators or neurotrans-
mitter systems to identify the mechanisms of positive feed-
back in reversal learning.
Strengths and weaknesses of the VPVD task
The design of the VPVD task comes with inherent strengths and
weaknesses. The main strength is that the probe trials, during
which rats choose between the intermediate stimulus and either
the positive or negative response options, allow us to track stim-
ulus preferences across the length of the reversal phase (from
initial performance, which is worse than chance, to an asymptote
above chance). This approach revealed that quinpirole treatment
selectively affects choice behaviour on the A− vs. C50/50 trials
and that this effect is most apparent during later sessions of
reversal learning. Our paradigm thus provides a novel method
for studying stimulus perseveration (inhibiting the response at
the previously rewarded stimulus, A−) and learned non-reward
(approaching a previously non-rewarded stimulus, B+) in visual
reversal learning, and builds upon previous work addressing
these phenomena using e.g. three response options or replace-
ment of one of the stimuli with a novel stimulus during the
reversal phase (Alsiö et al. 2015; Clarke et al. 2007; Piantadosi
et al. 2019); for a review, see (Nilsson et al. 2015). A selective
blockade of learning from negative feedback, as reported here, is
in agreement with previous findings of quinpirole-induced de-
lays in overcoming perseverative responding at the previously
correct response option in spatial reversal learning
(Boulougouris et al. 2009). However, our data (see Fig. 2)
strongly suggest that impaired learning from losses does not
equate to poor performance preferentially during the early phase
of visual discrimination reversal.
An alternative approach to studying learning from positive
and negative feedback is used in the probabilistic selection
task (Frank et al. 2004), where subjects initially learn the value
of stimulus pairs without any probe trials, and new pairings
are presented after learning has already taken place, in order to
explore whether subjects have learned from positive or nega-
tive feedback. In the context of two-choice visual reversal
learning (A− vs. B+), this approach can be implemented as
probe sessions with novel pairings (A− vs. C50/50 and B+ vs.
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C50/50) after a pre-defined number of trials or sessions (e.g.
every five sessions for rodents). Whereas this would not have
allowed us to follow the learning on a session-by-session ba-
sis, as the probe trials did in our design, the extent to which
rats had learned from positive or negative feedback could have
been evaluated in the drug-free state, separating the effects of
drugs on choice from the effects of drugs on learning. In
addition, although we here interpret choices on the probe trials
as reflecting the extent to which the rats have learned about
stimuli A and B during the standard trials, it is conceivable
that the rats are solving the three different pairings (Avs. B; A
vs. C50/50; B vs. C50/50) as separate problems. However, our
paradigm addresses this by presenting probe trials less fre-
quently than standard trials (one per eight trials versus six
per eight trials). It therefore seems likely that learning primar-
ily takes place during the standard A vs. B trials. Learning on
probe trials is also impeded by the probabilistic nature of the
feedback on these trials. The congruent effects of quinpirole at
0.25 mg/kg on negative probe trials in the VPVD task and
αloss in the PRL task supports the notion that performance
on the probe trials reflects the estimated value of the positive
and negative stimuli.
Conclusion
We used two different approaches and tasks to study howwins
and losses shape choice behaviour in reversal learning in the
rat. The first approach employed a behavioural probe during a
standard visual discrimination reversal task, while the second
involved computational modelling to define learning rates and
other latent factors underlying choice behaviour in a PRL task.
We report that the D2-like receptor agonist quinpirole has
profound and remarkably similar effects across the two tasks:
a complete blockade of learning from losses. These findings
extend previous work in rodents, non-human primates, and
humans, and is relevant for human disorders in which cogni-
tive flexibility is impaired, such as schizophrenia and
Parkinson’s disease.
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